{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:01Z","timestamp":1792097341550,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03400-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:24:39Z","timestamp":1789014279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From pumps to networks: ABC transporters in leukemia resistance and microenvironmental adaptation"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1188-5311","authenticated-orcid":false,"family":"Jyotirmayee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7448-7560","authenticated-orcid":false,"given":"Veerandra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-6086","authenticated-orcid":false,"given":"Malkhey","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"1","key":"3400_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/biomedicines12010111","volume":"12","author":"D Damiani","year":"2024","unstructured":"Damiani D, Tiribelli M, ATP-Binding Cassette Subfamily G. Member 2 in Acute Myeloid Leukemia: A New Molecular Target? Biomedicines. 2024;12(1):111. https:\/\/doi.org\/10.3390\/biomedicines12010111.","journal-title":"Biomedicines"},{"issue":"8","key":"3400_CR2","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.3390\/ijms24087147","volume":"24","author":"D Damiani","year":"2023","unstructured":"Damiani D, Tiribelli M. ABCG2 in acute myeloid leukemia: old and new perspectives. Int J Mol Sci. 2023;24(8):7147. https:\/\/doi.org\/10.3390\/ijms24087147.","journal-title":"Int J Mol Sci"},{"key":"3400_CR3","doi-asserted-by":"publisher","first-page":"115930","DOI":"10.1016\/j.biopha.2023.115930","volume":"170","author":"E Cerovska","year":"2024","unstructured":"Cerovska E, Salek C, Kundrat D, Sestakova S, Pesek A, Brozinova I, et al. ABC transporters are predictors of treatment failure in acute myeloid leukaemia. Biomed Pharmacother. 2024;170:115930. https:\/\/doi.org\/10.1016\/j.biopha.2023.115930.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3400_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12935-021-01746-w","volume":"21","author":"M Levin","year":"2021","unstructured":"Levin M, Stark M, Ofran Y, Assaraf YG. Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance. Cancer Cell Int. 2021;21(1):53. https:\/\/doi.org\/10.1186\/s12935-021-01746-w.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"3400_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3892\/ol.2020.12172","volume":"20","author":"W Jing","year":"2020","unstructured":"Jing W, Zhang X, Chen R, Ye X, Zhou M, Li W, et al. KD025, an anti-adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2-overexpressing leukemia cells. Oncol Lett. 2020;20(6):309. https:\/\/doi.org\/10.3892\/ol.2020.12172.","journal-title":"Oncol Lett"},{"issue":"7","key":"3400_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1182\/blood.2020009845","volume":"138","author":"G Borella","year":"2021","unstructured":"Borella G, Da Ros A, Borile G, Porc\u00f9 E, Tregnago C, Benetton M, et al. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia. Blood. 2021;138(7):557\u201370. https:\/\/doi.org\/10.1182\/blood.2020009845.","journal-title":"Blood"},{"issue":"21","key":"3400_CR7","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3390\/cancers13215319","volume":"13","author":"M Ciciarello","year":"2021","unstructured":"Ciciarello M, Corradi G, Forte D, Cavo M, Curti A. Emerging bone marrow microenvironment-driven mechanisms of drug resistance in acute myeloid leukemia: tangle or chance? Cancers. 2021;13(21):5319. https:\/\/doi.org\/10.3390\/cancers13215319.","journal-title":"Cancers"},{"issue":"2","key":"3400_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ijc.34684","volume":"154","author":"C Allert","year":"2024","unstructured":"Allert C, M\u00fcller-Tidow C, Blank MF. The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia. Int J Cancer. 2024;154(2):197\u2013209. https:\/\/doi.org\/10.1002\/ijc.34684.","journal-title":"Int J Cancer"},{"key":"3400_CR9","doi-asserted-by":"publisher","first-page":"096032712513946","DOI":"10.1177\/09603271251394693","volume":"44","author":"MH Abdallah","year":"2025","unstructured":"Abdallah MH, Atia HA, Elariny HA, Khalifa AM, Saleh A, Kabel AM. Omarigliptin\/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1\/RAGE\/TLR4 signaling, and p38\/ERK\/JNK MAPKs. Hum Exp Toxicol. 2025;44:09603271251394693.","journal-title":"Hum Exp Toxicol"},{"key":"3400_CR10","doi-asserted-by":"publisher","unstructured":"GM, CX-Y, HP, FJS, YD-H, WZ-X, et al. Understanding and overcoming multidrug resistance in cancer. Nat Rev Clin Oncol. 2025;1\u201321. https:\/\/doi.org\/10.1038\/s41571-025-01059-1.","DOI":"10.1038\/s41571-025-01059-1"},{"issue":"11","key":"3400_CR11","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3390\/molecules25112517","volume":"25","author":"M Cagala","year":"2020","unstructured":"Cagala M, Pavlikova L, Seres M, Kadlecikova K, Breier A, Sulova Z. Development of resistance to endoplasmic reticulum stress-inducing agents in mouse leukemic L1210 cells. Molecules. 2020;25(11):2517. https:\/\/doi.org\/10.3390\/molecules25112517.","journal-title":"Molecules"},{"issue":"11","key":"3400_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cells10112833.33","volume":"10","author":"SM Bolandi","year":"2021","unstructured":"Bolandi SM, Pakjoo M, Beigi P, Kiani M, Allahgholipour A, Goudarzi N, et al. A role for the bone marrow microenvironment in drug resistance of acute myeloid leukemia. Cells. 2021;10(11):28. https:\/\/doi.org\/10.3390\/cells10112833.33.","journal-title":"Cells"},{"issue":"6","key":"3400_CR13","doi-asserted-by":"publisher","first-page":"e896","DOI":"10.1097\/HS9.0000000000000896","volume":"7","author":"C Tomasoni","year":"2023","unstructured":"Tomasoni C, Pievani A, Rambaldi B, Biondi A, Serafini M. A question of frame: the role of the bone marrow stromal niche in myeloid malignancies. Hemasphere. 2023;7(6):e896. https:\/\/doi.org\/10.1097\/HS9.0000000000000896.","journal-title":"Hemasphere"},{"issue":"2","key":"3400_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.arcmed.2022.12.008","volume":"54","author":"Y Kargar-Sichani","year":"2023","unstructured":"Kargar-Sichani Y, Mohammadi MH, Amiri V, Barzegar M, Keshavarz A, Bashash D, Farsani MA. Effect of acute myeloid leukemia-derived extracellular vesicles on bone marrow mesenchymal stromal cells: expression of poor prognosis genes. Arch Med Res. 2023;54(2):95\u2013104. https:\/\/doi.org\/10.1016\/j.arcmed.2022.12.008.","journal-title":"Arch Med Res"},{"issue":"1","key":"3400_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11033-024-09674-4","volume":"51","author":"M Amirpour","year":"2024","unstructured":"Amirpour M, Kuhestani-Dehaghi B, Kheyrandish S, Hajipirloo LK, Khaffafpour Z, Keshavarz F, Allahbakhshian-Farsani M. The impact of exosomes derived from B-cell acute lymphoblastic leukemia as a growth factor on bone marrow mesenchymal stromal cells. Mol Biol Rep. 2024;51(1):749. https:\/\/doi.org\/10.1007\/s11033-024-09674-4.","journal-title":"Mol Biol Rep"},{"issue":"9","key":"3400_CR16","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3390\/ijms23094657","volume":"23","author":"Y Sbirkov","year":"2022","unstructured":"Sbirkov Y, Vergov B, Mehterov N, Sarafian V. miRNAs in lymphocytic leukaemias\u2014the miRror of drug resistance. Int J Mol Sci. 2022;23(9):4657. https:\/\/doi.org\/10.3390\/ijms23094657.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3400_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei S, Pollyea DA, Gustafson A, Stevens BM, Minhajuddin M, Fu R, et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 2020;10(4):536\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0710.","journal-title":"Cancer Discov"},{"issue":"5","key":"3400_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/ejh.13492","volume":"105","author":"M Hormi","year":"2020","unstructured":"Hormi M, Birsen R, Belhadj M, Huynh T, Cantero Aguilar L, Grignano E, et al. Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3\u2010mimetics in AML. Eur J Haematol. 2020;105(5):588\u201396. https:\/\/doi.org\/10.1111\/ejh.13492.","journal-title":"Eur J Haematol"},{"key":"3400_CR19","doi-asserted-by":"publisher","first-page":"659253","DOI":"10.3389\/fonc.2021.659253","volume":"11","author":"N Van Gils","year":"2021","unstructured":"Van Gils N, Denkers F, Smit L. Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia. Front Oncol. 2021;11:659253. https:\/\/doi.org\/10.3389\/fonc.2021.659253.","journal-title":"Front Oncol"},{"issue":"1","key":"3400_CR20","doi-asserted-by":"publisher","first-page":"2527015","DOI":"10.1080\/20565623.2025.2527015","volume":"11","author":"C Liang","year":"2025","unstructured":"Liang C, Lin J-Y, Liao L-H, Song S-y, Dai J-T, Chen J-J, et al. Plasma metabolic landscape unveils key regulators of leukemia subtype progression. Future Sci OA. 2025;11(1):2527015. https:\/\/doi.org\/10.1080\/20565623.2025.2527015.","journal-title":"Future Sci OA"},{"issue":"22","key":"3400_CR21","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.3390\/cancers13225822","volume":"13","author":"K Ito","year":"2021","unstructured":"Ito K, Ito K. Leukemia stem cells as a potential target to achieve therapy-free remission in chronic myeloid leukemia. Cancers. 2021;13(22):5822. https:\/\/doi.org\/10.3390\/cancers13225822.","journal-title":"Cancers"},{"issue":"11","key":"3400_CR22","doi-asserted-by":"publisher","first-page":"e17810","DOI":"10.15252\/emmm.202317810","volume":"15","author":"D Magliulo","year":"2023","unstructured":"Magliulo D, Simoni M, Caserta C, Fracassi C, Belluschi S, Giannetti K, et al. The transcription factor HIF2\u03b1 partakes in the differentiation block of acute myeloid leukemia. EMBO Mol Med. 2023;15(11):e17810. https:\/\/doi.org\/10.15252\/emmm.202317810.","journal-title":"EMBO Mol Med"},{"key":"3400_CR23","doi-asserted-by":"publisher","first-page":"109094","DOI":"10.1016\/j.clim.2022.109094","volume":"242","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Liu Z, Wan Y, Zou L, Liu L, Ding S, et al. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1\u03b1 expression. Clin Immunol. 2022;242:109094. https:\/\/doi.org\/10.1016\/j.clim.2022.109094.","journal-title":"Clin Immunol"},{"key":"3400_CR24","doi-asserted-by":"publisher","first-page":"1422565","DOI":"10.3389\/fphar.2024.1422565","volume":"15","author":"M Kaehler","year":"2024","unstructured":"Kaehler M, von Bubnoff N, Cascorbi I, Gorantla SP. Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms. Front Pharmacol. 2024;15:1422565. https:\/\/doi.org\/10.3389\/fphar.2024.1422565.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3400_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14(1):54. https:\/\/doi.org\/10.1186\/s40164-025-00647-2.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"3400_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12967-025-06423-4","volume":"23","author":"S Guo","year":"2025","unstructured":"Guo S, Bourova-Flin E, Rousseaux S, Chuffart F, Peng L, Jing D, et al. Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia. J Transl Med. 2025;23(1):542. https:\/\/doi.org\/10.1186\/s12967-025-06423-4.","journal-title":"J Transl Med"},{"issue":"2","key":"3400_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4081\/oncol.2020.448","volume":"14","author":"SK Gupta","year":"2020","unstructured":"Gupta SK, Singh P, Ali V, Verma M. Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncol Rev. 2020;14(2):448. https:\/\/doi.org\/10.4081\/oncol.2020.448.","journal-title":"Oncol Rev"},{"issue":"7","key":"3400_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18(7):452\u201364. https:\/\/doi.org\/10.1038\/s41568-018-0005-8.","journal-title":"Nat Rev Cancer"},{"key":"3400_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/978-981-13-7647-4_12","volume":"1141","author":"H Amawi","year":"2019","unstructured":"Amawi H, Sim H-M, Tiwari AK, Ambudkar SV, Shukla S. ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol. 2019;1141:549\u201380. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_12.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"3400_CR30","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1124\/mol.112.079129","volume":"82","author":"CQ Xia","year":"2012","unstructured":"Xia CQ, Smith PG. Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation. Mol Pharmacol. 2012;82(6):1008\u201321. https:\/\/doi.org\/10.1124\/mol.112.079129.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"3400_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/ijms26104701","volume":"10","author":"AC Rodrigues","year":"2009","unstructured":"Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics. 2009;10(6):1007\u201316. https:\/\/doi.org\/10.3390\/ijms26104701.","journal-title":"Pharmacogenomics"},{"issue":"10","key":"3400_CR32","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.3390\/ijms26104701","volume":"26","author":"P \u00c1lvarez-Carrasco","year":"2025","unstructured":"\u00c1lvarez-Carrasco P, Morales-Villamil F, Maldonado-Bernal C. P-Glycoprotein as a Therapeutic Target in Hematological Malignancies: A Challenge to Overcome. Int J Mol Sci. 2025;26(10):4701. https:\/\/doi.org\/10.3390\/ijms26104701.","journal-title":"Int J Mol Sci"},{"key":"3400_CR33","doi-asserted-by":"publisher","unstructured":"Knight B, Tammara B, Modi NB, Dallas S, Mardirosian S, Wang J, et al. Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling. Dermatol Ther. 2025;1\u201326. https:\/\/doi.org\/10.1007\/s13555-025-01454-7.","DOI":"10.1007\/s13555-025-01454-7"},{"key":"3400_CR34","doi-asserted-by":"publisher","unstructured":"Hallis SP, Go BJ, Yoo JM, Cho GH, Kwak M-K. Toward a Better Understanding of NRF2\/NFE2L2 and BCRP\/ABCG2 in Therapy Resistance in Cancer. Drug Targets Ther (DTT). 2023;2(2111\u201323. https:\/\/doi.org\/10.58502\/DTT.23.0021.","DOI":"10.58502\/DTT.23.0021"},{"issue":"2","key":"3400_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/cancers13020326","volume":"13","author":"D Sinha","year":"2021","unstructured":"Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Trends in research on exosomes in cancer progression and anticancer therapy. Cancers. 2021;13(2):326. https:\/\/doi.org\/10.3390\/cancers13020326.","journal-title":"Cancers"},{"issue":"11","key":"3400_CR36","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/pharmaceutics15112535","volume":"15","author":"NE Verhagen","year":"2023","unstructured":"Verhagen NE, Koenderink JB, Blijlevens NM, Janssen JJ, Russel FG. Transporter-mediated cellular distribution of tyrosine kinase inhibitors as a potential resistance mechanism in chronic myeloid leukemia. Pharmaceutics. 2023;15(11):2535. https:\/\/doi.org\/10.3390\/pharmaceutics15112535.","journal-title":"Pharmaceutics"},{"issue":"21","key":"3400_CR37","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1002\/cncr.32904","volume":"126","author":"WG Blum","year":"2020","unstructured":"Blum WG, Mims AS. Treating acute myeloid leukemia in the modern era: A primer. Cancer. 2020;126(21):4668\u201377. https:\/\/doi.org\/10.1002\/cncr.32904.","journal-title":"Cancer"},{"issue":"4","key":"3400_CR38","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/pharmaceutics14040878","volume":"14","author":"JE Meg\u00edas-Vericat","year":"2022","unstructured":"Meg\u00edas-Vericat JE, Mart\u00ednez-Cuadr\u00f3n D, Solana-Altabella A, Poveda JL, Montesinos P. Systematic review of pharmacogenetics of ABC and SLC transporter genes in acute myeloid leukemia. Pharmaceutics. 2022;14(4):878. https:\/\/doi.org\/10.3390\/pharmaceutics14040878.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3400_CR39","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/ijms25105246","volume":"130","author":"MS Williams","year":"2020","unstructured":"Williams MS, Amaral FM, Simeoni F, Somervaille TC. A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia. J Clin Invest. 2020;130(3):1217\u201332. https:\/\/doi.org\/10.3390\/ijms25105246.","journal-title":"J Clin Invest"},{"issue":"18","key":"3400_CR40","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.7150\/jca.52641","volume":"12","author":"J Yi","year":"2021","unstructured":"Yi J, Wang L, Wang X-Y, Sun J, Yin X-Y, Hou J-X, et al. Suppression of aberrant activation of NF-\u03baB pathway in drug-resistant leukemia stem cells contributes to parthenolide-potentiated reversal of drug resistance in leukemia. J Cancer. 2021;12(18):5519. https:\/\/doi.org\/10.7150\/jca.52641.","journal-title":"J Cancer"},{"issue":"10","key":"3400_CR41","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.3390\/ijms25105246","volume":"25","author":"K Wi\u015bniewski","year":"2024","unstructured":"Wi\u015bniewski K, Pu\u0142a B. A review of resistance mechanisms to Bruton\u2019s kinase inhibitors in chronic lymphocytic leukemia. Int J Mol Sci. 2024;25(10):5246. https:\/\/doi.org\/10.3390\/ijms25105246.","journal-title":"Int J Mol Sci"},{"key":"3400_CR42","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1200\/jco.2025.43.16_suppl.7036","volume":"43","author":"P Ghia","year":"2025","unstructured":"Ghia P, Barr PM, Allan JN, Siddiqi T, Tedeschi A, Kipps TJ, et al. Final analysis of fixed-duration ibrutinib+ venetoclax for chronic lymphocytic leukemia (CLL)\/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. J Clin Oncol. 2025;43:7036. https:\/\/doi.org\/10.1200\/jco.2025.43.16_suppl.7036.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3400_CR43","doi-asserted-by":"publisher","first-page":"1705730","DOI":"10.1080\/23723556.2019.1705730","volume":"7","author":"MS Williams","year":"2020","unstructured":"Williams MS, Somervaille TC. Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia. Mol Cell Oncol. 2020;7(2):1705730. https:\/\/doi.org\/10.1080\/23723556.2019.1705730.","journal-title":"Mol Cell Oncol"},{"issue":"9","key":"3400_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3324\/haematol.2010.031823","volume":"96","author":"C Marzac","year":"2011","unstructured":"Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, et al. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica. 2011;96(9):1293. https:\/\/doi.org\/10.3324\/haematol.2010.031823.","journal-title":"Haematologica"},{"issue":"1","key":"3400_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Li S, Wang H, Zhou J, Li S, Chen G, et al. A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t (8; 21) acute myeloid leukemia. Exp Hematol Oncol. 2024;13(1):9. https:\/\/doi.org\/10.1186\/s40164-024-00480-z.","journal-title":"Exp Hematol Oncol"},{"key":"3400_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2024.10.009","author":"X Tang","year":"2024","unstructured":"Tang X, Li K, Wang Y, Rocchi S, Shen S, Cerezo M. Metabolism and mRNA translation: a nexus of cancer plasticity. Trends Cell Biol. 2024. https:\/\/doi.org\/10.1016\/j.tcb.2024.10.009.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"3400_CR47","doi-asserted-by":"publisher","first-page":"104076","DOI":"10.4251\/wjgo.v17.i5.104076","volume":"17","author":"J-N Liao","year":"2025","unstructured":"Liao J-N, Ni W-J, Wu P-H, Yang Y-D, Yang Y, Long W, et al. Switching from messenger RNAs to noncoding RNAs, METTL3 is a novel colorectal cancer diagnosis and treatment target. World J Gastrointest Oncol. 2025;17(5):104076. https:\/\/doi.org\/10.4251\/wjgo.v17.i5.104076.","journal-title":"World J Gastrointest Oncol"},{"key":"3400_CR48","doi-asserted-by":"publisher","first-page":"634044","DOI":"10.3389\/fcell.2021.634044","volume":"9","author":"FM Roversi","year":"2021","unstructured":"Roversi FM, Bueno MLP, Pericole FV, Saad STO. Hematopoietic cell kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12\/CXCR4 axis. Front Cell Dev Biol. 2021;9:634044. https:\/\/doi.org\/10.3389\/fcell.2021.634044.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3400_CR49","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/ijms25052527","volume":"22","author":"C-P Wu","year":"2021","unstructured":"Wu C-P, Hung C-Y, Lusvarghi S, Chang Y-F, Hsiao S-H, Huang Y-H, et al. Overexpression of human ABCB1 and ABCG2 reduces the susceptibility of cancer cells to the histone deacetylase 6-specific inhibitor Citarinostat. Int J Mol Sci. 2021;22(5):2592. https:\/\/doi.org\/10.3390\/ijms25052527.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3400_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108(2):353.","journal-title":"Haematologica"},{"issue":"17","key":"3400_CR51","doi-asserted-by":"publisher","first-page":"16355","DOI":"10.1021\/acsnano.4c15736","volume":"19","author":"R Zhang","year":"2025","unstructured":"Zhang R, Guo L, Li Q, Liang Y, Liao Y, Xu H, et al. Biodegradable Carrier-Free Nanomedicine via Self-Assembly of Pure Drug Molecules for Triple Sensitization of Radiotherapy. ACS Nano. 2025;19(17):16355\u201371. https:\/\/doi.org\/10.1021\/acsnano.4c15736.","journal-title":"ACS Nano"},{"issue":"14","key":"3400_CR52","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.3390\/cancers14143303","volume":"14","author":"A Fallati","year":"2022","unstructured":"Fallati A, Di Marzo N, D\u2019Amico G, Dander E. Mesenchymal stromal cells (MSCs): an ally of B-cell acute lymphoblastic leukemia (B-ALL) cells in disease maintenance and progression within the bone marrow hematopoietic niche. Cancers. 2022;14(14):3303. https:\/\/doi.org\/10.3390\/cancers14143303.","journal-title":"Cancers"},{"issue":"5","key":"3400_CR53","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/ijms25052527","volume":"25","author":"C-H Wu","year":"2024","unstructured":"Wu C-H, Weng T-F, Li J-P, Wu K-H. Biology and therapeutic properties of mesenchymal stem cells in leukemia. Int J Mol Sci. 2024;25(5):2527. https:\/\/doi.org\/10.3390\/ijms25052527.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3400_CR54","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3324\/haematol.2018.214379","volume":"105","author":"L Boutin","year":"2019","unstructured":"Boutin L, Arnautou P, Trignol A, S\u00e9got A, Farge T, Desterke C, et al. Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation. Haematologica. 2019;105(4):987. https:\/\/doi.org\/10.3324\/haematol.2018.214379.","journal-title":"Haematologica"},{"issue":"9","key":"3400_CR55","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/leu.2009.76","volume":"23","author":"M Bebawy","year":"2009","unstructured":"Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau G. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia. 2009;23(9):1643\u20139. https:\/\/doi.org\/10.1038\/leu.2009.76.","journal-title":"Leukemia"},{"issue":"5","key":"3400_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/biom15050685","volume":"15","author":"G Liu","year":"2025","unstructured":"Liu G, Liu J, Li S, Zhang Y, Ren H. Exosome-mediated chemoresistance in cancers: mechanisms, therapeutic implications, and future directions. Biomolecules. 2025;15(5):685. https:\/\/doi.org\/10.3390\/biom15050685.","journal-title":"Biomolecules"},{"issue":"4","key":"3400_CR57","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/ijms25041994","volume":"25","author":"\u00c0 Bistu\u00e9-Rovira","year":"2024","unstructured":"Bistu\u00e9-Rovira \u00c0, Rico LG, Bardina J, Junc\u00e0 J, Granada I, Bradford JA, et al. Persistence of Chronic Lymphocytic Leukemia Stem-like Populations under Simultaneous In Vitro Treatment with Curcumin, Fludarabine, and Ibrutinib: Implications for Therapy Resistance. Int J Mol Sci. 2024;25(4):1994. https:\/\/doi.org\/10.3390\/ijms25041994.","journal-title":"Int J Mol Sci"},{"key":"3400_CR58","doi-asserted-by":"publisher","first-page":"1584630","DOI":"10.3389\/fcell.2025.1584630","volume":"13","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li K, Li L, Li Q, Qi Y, Liu K, et al. The role and therapeutic potential of glucose metabolism in multidrug resistance of cancer. Front Cell Dev Biol. 2025;13:1584630. https:\/\/doi.org\/10.3389\/fcell.2025.1584630.","journal-title":"Front Cell Dev Biol"},{"key":"3400_CR59","doi-asserted-by":"publisher","unstructured":"Xun X, Cheng J, Wang H, Zhao L, Deng P, Wang Y, et al. Gene Network Analysis Reveals the Responsive Cascades of Scallop (Patinopecten yessoensis) Exposed to Toxic Alexandrium catenella. Mar Environ Res. 2025;107265. https:\/\/doi.org\/10.1016\/j.marenvres.2025.107265.","DOI":"10.1016\/j.marenvres.2025.107265"},{"issue":"1","key":"3400_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/lymphatics3010006","volume":"3","author":"CO Ramos Pe\u00f1afiel","year":"2025","unstructured":"Ramos Pe\u00f1afiel CO, Mart\u00ednez Tovar A, P\u00e9rez S\u00e1mano D, Cer\u00f3n Maldonado R, Gallardo Rodr\u00edguez AG, Mart\u00ednez Murillo C. Olarte Carrillo I. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics. 2025;3(1):6.","journal-title":"Lymphatics"},{"issue":"4","key":"3400_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/1735-5362.378085","volume":"18","author":"B Samii","year":"2023","unstructured":"Samii B, Jafarian A, Rabbani M, Zolfaghari B, Rahgozar S, Pouraboutaleb E. The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia. Res Pharm Sci. 2023;18(4):381\u201391. https:\/\/doi.org\/10.4103\/1735-5362.378085.","journal-title":"Res Pharm Sci"},{"issue":"11","key":"3400_CR62","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","volume":"24","author":"JC Christianson","year":"2023","unstructured":"Christianson JC, Jarosch E, Sommer T. Mechanisms of substrate processing during ER-associated protein degradation. Nat Rev Mol Cell Biol. 2023;24(11):777\u201396. https:\/\/doi.org\/10.1038\/s41580-023-00633-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3400_CR63","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/ijms27052207","volume":"27","author":"MY Kordyukova","year":"2026","unstructured":"Kordyukova MY, Bulgakov TK, Sorokina MA, Kudryashova OM, Abakumova TO, Meshcheryakova VI, et al. Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine. Int J Mol Sci. 2026;27(5):2207. https:\/\/doi.org\/10.3390\/ijms27052207.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3400_CR64","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1182\/blood.v98.12.3212","volume":"98","author":"AF List","year":"2001","unstructured":"List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, et al. Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. Blood. 2001;98(12):3212\u201320. https:\/\/doi.org\/10.1182\/blood.v98.12.3212.","journal-title":"Blood"},{"issue":"6","key":"3400_CR65","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00280-024-04656-6","volume":"93","author":"JF Marcelletti","year":"2024","unstructured":"Marcelletti JF, Sikic BI. Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype. Cancer Chemother Pharmacol. 2024;93(6):595\u2013604. https:\/\/doi.org\/10.1007\/s00280-024-04656-6.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"19","key":"3400_CR66","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/cancers13194820","volume":"13","author":"R Alves","year":"2021","unstructured":"Alves R, Gon\u00e7alves AC, Rutella S, Almeida AM, De Las Rivas J, Trougakos IP, Sarmento Ribeiro AB. Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia\u2014from molecular mechanisms to clinical relevance. Cancers. 2021;13(19):4820. https:\/\/doi.org\/10.3390\/cancers13194820.","journal-title":"Cancers"},{"key":"3400_CR67","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1182\/blood-2021-153181","volume":"138","author":"VM Shastri","year":"2021","unstructured":"Shastri VM, Chauhan L, Alonzo TA, Wang Y-C, Aplenc R, Hirsch BA, et al. A Polygenic DNA Damage Repair Pharmacogenomics (DDR_PGx8) Score Predicts GO Response in AML. Blood. 2021;138:3456. https:\/\/doi.org\/10.1182\/blood-2021-153181.","journal-title":"Blood"},{"issue":"20","key":"3400_CR68","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.3390\/cancers15204957","volume":"15","author":"J Xu","year":"2023","unstructured":"Xu J, Dong X, Huang DC, Xu P, Zhao Q, Chen B. Current advances and future strategies for BCL-2 inhibitors: potent weapons against cancers. Cancers. 2023;15(20):4957. https:\/\/doi.org\/10.3390\/cancers15204957.","journal-title":"Cancers"},{"issue":"7","key":"3400_CR69","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/1568009620666200424150321","volume":"20","author":"S Horibata","year":"2020","unstructured":"Horibata S, Alyateem G, DeStefano CB, Gottesman MM. The evolving AML genomic landscape: therapeutic implications. Curr Cancer Drug Targets. 2020;20(7):532\u201344. https:\/\/doi.org\/10.2174\/1568009620666200424150321.","journal-title":"Curr Cancer Drug Targets"},{"issue":"11","key":"3400_CR70","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1158\/1078-0432.CCR-08-2048","volume":"15","author":"S Hauswald","year":"2009","unstructured":"Hauswald S, Duque-Afonso J, Wagner MM, Schertl FM, L\u00fcbbert M, Peschel C, et al. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clin Cancer Res. 2009;15(11):3705\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2048.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3400_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.exphem.2007.11.014","volume":"36","author":"MM Ho","year":"2008","unstructured":"Ho MM, Hogge DE, Ling V. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Exp Hematol. 2008;36(4):433\u201342. https:\/\/doi.org\/10.1016\/j.exphem.2007.11.014.","journal-title":"Exp Hematol"},{"issue":"5","key":"3400_CR72","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3892\/ol.2018.8095","volume":"15","author":"B Liu","year":"2018","unstructured":"Liu B, Li L-J, Gong X, Zhang W, Zhang H, Zhao L. Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia. Oncol Lett. 2018;15(5):6671\u20137. https:\/\/doi.org\/10.3892\/ol.2018.8095.","journal-title":"Oncol Lett"},{"issue":"2","key":"3400_CR73","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1532\/IJH97.E0624","volume":"86","author":"M Kourti","year":"2007","unstructured":"Kourti M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, Papageorgiou T, et al. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J Hematol. 2007;86(2):166\u201373.","journal-title":"Int J Hematol"},{"key":"3400_CR74","doi-asserted-by":"publisher","first-page":"1331687","DOI":"10.3389\/fphar.2023.1331687","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Fang H, Sun H, Wu X, Xu Y, Zhou B-BS, Li H. Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells. Front Pharmacol. 2024;14:1331687. https:\/\/doi.org\/10.3389\/fphar.2023.1331687.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3400_CR75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41419-025-07831-6","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Liu G, Chen Z, Li K, Yu Z, He C, et al. Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis. Cell Death Dis. 2025;16(1):627.","journal-title":"Cell Death Dis"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03400-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:05Z","timestamp":1792096925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03400-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3400"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03400-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review article does not need ethical approval.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have not used any AI tool for the writing of the manuscript.","order":4,"name":"Ethics","label":"Generative AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Formal consent is not required for this type of study.","order":5,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"274"}}